Source:http://linkedlifedata.com/resource/pubmed/id/11423668
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-6-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1083-7159
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
230-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11423668-Antineoplastic Agents,
pubmed-meshheading:11423668-Genes, abl,
pubmed-meshheading:11423668-Humans,
pubmed-meshheading:11423668-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:11423668-Medical Oncology,
pubmed-meshheading:11423668-Piperazines,
pubmed-meshheading:11423668-Pyrimidines
|
pubmed:year |
2001
|
pubmed:articleTitle |
The oncologic four-minute mile.
|
pubmed:publicationType |
Editorial,
Comment
|